Concerns Rise Over Upcoming Flu Season
Public health officials and specialists in infectious diseases are sounding alarms regarding this year’s flu outbreak.
The UK’s National Health Service (NHS) has raised an “SOS” alert, expressing fears that this winter could bring an unusually severe wave of influenza, as reported by the BBC.
“This year’s flu season is likely to be particularly bad,” said Dr. Jacob Granville, CEO of the biotech firm Sentivax. He added that the UK is currently experiencing a rapid surge, with infection rates three times higher than last year.
Australia reportedly had its worst flu season on record in 2024, and there’s a tendency for their patterns to indicate what might happen in the northern hemisphere.
Early signs in the United States suggest a similar trend.
“We see early signs of influenza activity in several parts of the country,” noted Dr. Ravi Jhaveri from Northwestern University Feinberg School of Medicine, highlighting that vaccination rates have been declining since the pandemic.
Experts warn that this combination of factors could make upcoming seasons challenging, particularly as the H3N2 virus is gaining traction, which might correlate with decreasing effectiveness of flu vaccines.
“On one hand, the vaccines include strains that are quite outdated,” Granville commented. “They’re based on 2021, 2022, and 2023 strains, meaning they may not align well with the circulating virus.”
He also emphasized that the current strain is historically linked to more severe illness and increased hospitalization rates, compounded by ongoing mutations making it tough for the immune system to recognize.
Jhaveri pointed out that while flu seasons can vary significantly, the interactions among respiratory viruses may be shifting.
“Typically, influenza outbreaks follow the peak of RSV epidemics,” he explained. “But newer preventive measures for RSV might be altering the overall pattern of respiratory viruses.”
Though vaccinations are still advisable, Granville cautioned that their efficacy might be “partial at best and possibly worse than usual.” He stressed the importance of vaccination, particularly as immunity tends to diminish over time, especially in elderly individuals.
While data from Australia suggests that vaccines might still offer a reasonable level of protection, high-risk groups—like those with chronic illnesses, weakened immune systems, pregnant women, and young children—should exercise extra caution.
Jhaveri shared a concerning statistic: “About half of the children who die from influenza or related complications have no prior risk factors,” reinforcing that vaccination is crucial in preventing influenza.
For those reluctant to visit clinics, Jhaveri mentioned that nasal spray vaccines have been approved for self-administration, enabling family members to administer them at home.
Granville also noted that Sentivax is developing a universal influenza vaccine, with plans to begin human trials in early 2026.
